Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-06

Clinical Trial Update: Phase 1 Crohn's Pediatric Sub-study of MSC AFP [Phase 1]

View source ↗

Summary

Phase 1 Crohn's disease pediatric sub-study of MSC AFP for perianal fistula has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MSC AFP

Snippet

Sponsor: William A. Faubion, M.D. | Conditions: Perianal Fistula | Phase 1 | Status: WITHDRAWN